Autopsy report · NCT02976441
Autologous Stem Cell Collection and Reinfusion in Newly Diagnosed High Grade Gliomas
Cause of deathFunding or business
“Physician decided not to go through with study”
Life of this trial
- Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.
Vital statistics
- Status
- Withdrawn
- Phase
- Early Phase 1
- Sponsor
- Washington University School of Medicine
- Sponsor type
- University, hospital or other
- Conditions
- Astrocytoma; Brainstem Glioma; Ependymoma; Mixed Glioma; Oligodendroglioma; Optic Nerve Glioma
- Interventions
- Radiation therapy; Temozolomide; Stem cell collection; Stem cell infusion
- Participants
- 0
Trials that died the same way
- Effects of 3% Sodium Chloride on Post-operative Dysphagia Following Anterior Cervical Spine Surgery
“Resident physician decided not to proceed with study” - Genes Mutation Pentalogy of Cantrell
“Physician's chose to not follow through with the study.” - Crossover Evaluation of Effect of Atorvastatin on PK of Irinotecan in CRC Patients Receiving FOLFIRI
“Study was withdrawn due to lack of patient enrollment.” - Magnetic Resonance-guided High-Intensity Focused Ultrasound (MR-HIFU) Used for Mild Hyperthermia
“Decision was made to not go forward with the study” - Evaluation of Use of Plastic Bags to Prevent Neonatal Hypothermia-Part III
“no personnel available to enroll in study- decision made to not complete”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.